LU85231A1 - Benzamid-derivate - Google Patents

Benzamid-derivate Download PDF

Info

Publication number
LU85231A1
LU85231A1 LU85231A LU85231A LU85231A1 LU 85231 A1 LU85231 A1 LU 85231A1 LU 85231 A LU85231 A LU 85231A LU 85231 A LU85231 A LU 85231A LU 85231 A1 LU85231 A1 LU 85231A1
Authority
LU
Luxembourg
Prior art keywords
aminoethyl
acid addition
compound
compounds according
hydrogen
Prior art date
Application number
LU85231A
Other languages
German (de)
English (en)
Inventor
Emilio Kyburz
Mose Da Prada
Renato Joos
Pierre Charles Wyss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of LU85231A1 publication Critical patent/LU85231A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU85231A 1983-03-03 1984-02-29 Benzamid-derivate LU85231A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH115083 1983-03-03
CH1150/83A CH653670A5 (de) 1983-03-03 1983-03-03 Benzamid-derivate.

Publications (1)

Publication Number Publication Date
LU85231A1 true LU85231A1 (de) 1985-09-12

Family

ID=4203649

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85231A LU85231A1 (de) 1983-03-03 1984-02-29 Benzamid-derivate

Country Status (28)

Country Link
JP (1) JPS59167552A (ja)
KR (1) KR910008202B1 (ja)
AR (1) AR243155A1 (ja)
AT (1) AT390948B (ja)
AU (2) AU570431B2 (ja)
BE (1) BE899059A (ja)
CA (1) CA1252794A (ja)
CH (1) CH653670A5 (ja)
DE (1) DE3407654C2 (ja)
DK (1) DK166382C (ja)
ES (3) ES530230A0 (ja)
FI (1) FI79297C (ja)
FR (1) FR2541996B1 (ja)
GB (1) GB2135998B (ja)
GR (1) GR81866B (ja)
HU (1) HU193556B (ja)
IE (1) IE57004B1 (ja)
IL (1) IL71078A (ja)
IT (1) IT1173365B (ja)
LU (1) LU85231A1 (ja)
MC (1) MC1568A1 (ja)
NL (1) NL8400459A (ja)
NO (1) NO165999C (ja)
NZ (1) NZ207272A (ja)
PH (1) PH19623A (ja)
PT (1) PT78187B (ja)
SE (1) SE466447B (ja)
ZA (1) ZA841394B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
FR2642972B1 (fr) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med Agents pour le diagnostic et le traitement des melanomes, derives halogenes aromatiques utilisables comme de tels agents et leur preparation
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342679A (en) * 1967-09-19 Parts by weight of acid chloride to react with parts of amine in
FR6557M (ja) * 1967-06-20 1968-12-23 Ile De France
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
DE2616486A1 (de) * 1976-04-14 1977-11-03 Basf Ag Farbstoffe der perylentetracarbonsaeurediimidreihe
CA1206964A (en) * 1980-11-12 1986-07-02 Nobuo Shinma Tetra-substituted benzene derivatives
DE3200258A1 (de) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
IL69997A0 (en) * 1983-01-03 1984-01-31 Miles Lab Procainamide and n-acetylprocainamide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
GB2135998B (en) 1986-09-24
DK147584D0 (da) 1984-02-29
FI79297C (fi) 1989-12-11
GR81866B (ja) 1984-12-12
IT8419778A0 (it) 1984-02-23
PT78187A (en) 1984-04-01
MC1568A1 (fr) 1985-02-04
NO165999B (no) 1991-02-04
JPH0430389B2 (ja) 1992-05-21
KR840009077A (ko) 1984-12-24
SE466447B (sv) 1992-02-17
AU8307987A (en) 1988-06-16
AU570431B2 (en) 1988-03-17
DK166382B (da) 1993-05-10
HU193556B (en) 1987-10-28
IL71078A0 (en) 1984-05-31
FR2541996B1 (fr) 1987-12-11
AR243155A1 (es) 1993-07-30
JPS59167552A (ja) 1984-09-21
ATA72484A (de) 1990-01-15
SE8401190L (sv) 1984-09-04
FR2541996A1 (fr) 1984-09-07
NO165999C (no) 1991-05-15
AT390948B (de) 1990-07-25
GB8405486D0 (en) 1984-04-04
AU609758B2 (en) 1991-05-09
IT1173365B (it) 1987-06-24
AU2506684A (en) 1984-09-06
NO840797L (no) 1984-09-04
PH19623A (ja) 1986-06-04
IL71078A (en) 1987-12-31
CA1252794A (en) 1989-04-18
FI840734A0 (fi) 1984-02-22
KR910008202B1 (ko) 1991-10-11
ES8504680A1 (es) 1985-05-01
ES537046A0 (es) 1985-08-16
ES8506600A1 (es) 1985-08-16
PT78187B (en) 1986-08-05
FI79297B (fi) 1989-08-31
ES537045A0 (es) 1985-08-16
DE3407654A1 (de) 1984-09-06
IE840512L (en) 1984-09-03
DK166382C (da) 1993-09-27
NZ207272A (en) 1987-07-31
CH653670A5 (de) 1986-01-15
FI840734A (fi) 1984-09-04
ZA841394B (en) 1985-06-26
ES8506601A1 (es) 1985-08-16
DE3407654C2 (de) 1994-04-07
IE57004B1 (en) 1992-03-11
NL8400459A (nl) 1984-10-01
ES530230A0 (es) 1985-05-01
GB2135998A (en) 1984-09-12
DK147584A (da) 1984-09-04
SE8401190D0 (sv) 1984-03-02
BE899059A (fr) 1984-09-03

Similar Documents

Publication Publication Date Title
DE4102024A1 (de) Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
AT391694B (de) Verfahren zur herstellung von neuen ethylendiaminmonoamid-derivaten
DE2558501C2 (ja)
DE3005580A1 (de) Guanidinobenzoesaeurederivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
CH678621A5 (ja)
EP0557879B1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
EP0021207B1 (de) Alphacarbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate die diese Verbindungen enthalten
EP0431371B1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
LU85231A1 (de) Benzamid-derivate
DD211552A5 (de) Verfahren zur herstellung von benzamidoverbindungen
US5238962A (en) Benzamide derivatives
DE3035688C2 (ja)
EP0665228A1 (de) Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel
EP0183190B1 (de) Benzamide und Salze
CH623044A5 (en) Process for the preparation of novel anilino-2-oxazolines
EP0491243B1 (de) Alkylaminoalkylamin- und -äther- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD209628A5 (de) Verfahren zur herstellung von imidazolinderivaten
EP0557877B1 (de) Lösliche Salze von 4-Amino-2-(4,4-dimethyl-imidazolidin-2-on-1-yl)-pyrimidin-5 -carbonsäure- N-methyl-N-(3-trifluormethyl-phenyl)- amid, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und Ausgangsprodukte
DE3027619A1 (de) 6-alkyl-7-phenyl-1,6-naphtyradin- 5(6h)-on-derivate
EP0816358A1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
CH633962A5 (en) Pharmaceutical preparations which contain pteridine compounds
DE2644820A1 (de) Cancerostatisch und immunstimulierend wirkende 1-(n-acyl-carbamoyl)-2-cyanaziridine sowie verfahren zur herstellung derselben
CH664755A5 (de) Aethylendiaminmonoamid-derivat.
EP0239533B1 (de) Pyridin-Derivate
CH661043A5 (en) Ethylenediamine monoamide derivatives